EE173 Economic Evaluation of Exagamglogene Autotemcel (EXA-CEL) Gene-Edited Therapy in Patients with Sickle Cell Disease with Recurrent Vaso-Occlusive Crises
Jun 1, 2023, 00:00
10.1016/j.jval.2023.03.474
https://www.valueinhealthjournal.com/article/S1098-3015(23)00574-0/fulltext
Title :
EE173 Economic Evaluation of Exagamglogene Autotemcel (EXA-CEL) Gene-Edited Therapy in Patients with Sickle Cell Disease with Recurrent Vaso-Occlusive Crises
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)00574-0&doi=10.1016/j.jval.2023.03.474
First page :
Section Title :
Open access? :
No
Section Order :
11860